Sugar, obesity and noncommunicable disease: Investor expectations

The fundamental aim behind these investor expectations is to better understand what food & beverage companies are doing to in response to the global rise in obesity and noncommunicable diseases (NCDs), which is a condition or disease that is non-infectious and non-transmissible among people. Our research has shown that the sector is exposed to increased regulation, changing consumer behaviour and greater scrutiny from public health bodies. It is our intention to seek an improved understanding of how companies are responding to these risks and opportunities in order that investors are able to better differentiate between leaders and laggards and reflect this in our company valuations.